Literature DB >> 8546204

Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene.

W G Chen1, Y Y Chen, M M Bacchi, C E Bacchi, M Alvarenga, L M Weiss.   

Abstract

Both Epstein-Barr virus (EBV) types A and B are found in endemic Burkitt's lymphoma (BL) occurring in equatorial Africa. We studied 17 cases of Brazilian BL previously demonstrated to be EBV-positive to determine the EBV type as well as the presence of a characteristic 30 bp deletion within the 3' end of the latent membrane protein-1 (LMP-1) gene that may be important to the pathogenesis of several EBV-associated neoplasms. All cases in which the age was known were children. We found type A EBV in 13 of 14 (93%) evaluable cases, and type B in one case. The LMP-1 deletion was found in 12 of 15 (80%) evaluable cases, including the one case of type B EBV, and a similar high prevalence (59%) of the deletion was detected in EBV-positive normal and reactive lymphoid tissues from individuals from the same geographic region. The high proportion of cases associated with type A EBV suggests that immunodeficiency is not an important factor in the pathogenesis of Brazilian BL, in contrast to endemic African BL. The presence of the LMP-1 deletion in a high prevalence in the normal population in this region is unexplained.

Entities:  

Mesh:

Year:  1996        PMID: 8546204      PMCID: PMC1861614     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.

Authors:  L S Young; Q Y Yao; C M Rooney; T B Sculley; D J Moss; H Rupani; G Laux; G W Bornkamm; A B Rickinson
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

2.  Detection of a second widespread strain of Epstein-Barr virus.

Authors:  J W Sixbey; P Shirley; P J Chesney; D M Buntin; L Resnick
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

3.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

Authors:  D Wang; D Liebowitz; F Wang; C Gregory; A Rickinson; R Larson; T Springer; E Kieff
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

Authors:  D Wang; D Liebowitz; E Kieff
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

6.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.

Authors:  J Sample; L Young; B Martin; T Chatman; E Kieff; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.

Authors:  T B Sculley; A Apolloni; L Hurren; D J Moss; D A Cooper
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

8.  Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.

Authors:  B Shiramizu; F Barriga; J Neequaye; A Jafri; R Dalla-Favera; A Neri; M Guttierez; P Levine; I Magrath
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

9.  Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients.

Authors:  B Borisch; J Finke; I Hennig; F Delacrétaz; J Schneider; P U Heitz; J A Laissue
Journal:  J Pathol       Date:  1992-10       Impact factor: 7.996

Review 10.  Burkitt's lymphoma.

Authors:  J L Ambrus; C M Ambrus
Journal:  J Med       Date:  1981
View more
  17 in total

1.  Rearranged Epstein-Barr virus genome in Hodgkin's disease and angioimmunoblastic lymphadenopathy: Swiss results.

Authors:  Hans Knecht; Bernhard F Odermatt
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 2.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance.

Authors:  Q Tao; R F Ambinder; L J Swinnen
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt's lymphoma cell lines based on the sequence of latent membrane protein 1.

Authors:  Kyosuke Kanai; Yukio Satoh; Yuriko Saiki; Haruo Ohtani; Takeshi Sairenji
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

5.  Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.

Authors:  Mario Alejandro Lorenzetti; Magdalena Gantuz; Jaime Altcheh; Elena De Matteo; Paola Andrea Chabay; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

6.  The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.

Authors:  K M Izumi; E D Cahir McFarland; E A Riley; D Rizzo; Y Chen; E Kieff
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.

Authors:  A G Scheinfeld; R G Nador; E Cesarman; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

8.  Viral studies in burkitt lymphoma: association with Epstein-Barr virus but not HHV-8.

Authors:  Eduardo M Queiroga; Gabriela Gualco; Lucimara Chioato; William J Harrington; Iguaracyra Araujo; Lawrence M Weiss; Carlos E Bacchi
Journal:  Am J Clin Pathol       Date:  2008-08       Impact factor: 2.493

9.  Association of neurotropic viruses in HIV-infected individuals who died of secondary complications of tuberculosis, cryptococcosis, or toxoplasmosis in South India.

Authors:  Rajesh Kannangai; Jaiprasath Sachithanandham; Anita Mahadevan; Asha Mary Abraham; Gopalan Sridharan; Anita Desai; Vasanthapuram Ravi; Susarla Krishna Shankar
Journal:  J Clin Microbiol       Date:  2013-01-02       Impact factor: 5.948

10.  Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.

Authors:  Eduardo M Queiroga; Gabriela Gualco; Lawrence M Weiss; Dirk P Dittmer; Iguaracyra Araujo; Claudette E N Klumb; William J Harrington; Carlos E Bacchi
Journal:  Am J Clin Pathol       Date:  2008-12       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.